338 related articles for article (PubMed ID: 32171629)
21. Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients.
Liu Z; Mao J; Wu X; Xu H; Wang X; Huang B; Zheng J; Nie M; Zhang H
Medicine (Baltimore); 2016 Mar; 95(9):e2867. PubMed ID: 26945370
[TBL] [Abstract][Full Text] [Related]
22. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
Lin J; Mao J; Wang X; Ma W; Hao M; Wu X
Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
[TBL] [Abstract][Full Text] [Related]
23. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
Mao JF; Wang X; Zheng JJ; Liu ZX; Xu HL; Huang BK; Nie M; Wu XY
Asian J Androl; 2018; 20(4):319-323. PubMed ID: 29516878
[TBL] [Abstract][Full Text] [Related]
25. Gonadotropin Treatment for the Male Hypogonadotropic Hypogonadism.
Boeri L; Capogrosso P; Salonia A
Curr Pharm Des; 2021; 27(24):2775-2783. PubMed ID: 32445446
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients.
Trabado S; Maione L; Bry-Gauillard H; Affres H; Salenave S; Sarfati J; Bouvattier C; Delemer B; Chanson P; Le Bouc Y; Brailly-Tabard S; Young J
J Clin Endocrinol Metab; 2014 Feb; 99(2):E268-75. PubMed ID: 24243640
[TBL] [Abstract][Full Text] [Related]
27. Gonadotropins for testicular descent in cryptorchid congenital hypogonadotropic hypogonadism males beyond infancy.
Sharma S; Shah R; Patil V; Lila AR; Sarathi V; Shah N; Bandgar T
J Pediatr Endocrinol Metab; 2021 Jul; 34(7):917-924. PubMed ID: 33894111
[TBL] [Abstract][Full Text] [Related]
28. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
Depenbusch M; von Eckardstein S; Simoni M; Nieschlag E
Eur J Endocrinol; 2002 Nov; 147(5):617-24. PubMed ID: 12444893
[TBL] [Abstract][Full Text] [Related]
29. Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: a systematic review and meta-analysis.
Gao Y; Yu B; Mao J; Wang X; Nie M; Wu X
BMC Endocr Disord; 2018 Nov; 18(1):85. PubMed ID: 30453944
[TBL] [Abstract][Full Text] [Related]
30. [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism].
Huang B; Mao J; Xu H; Wang X; Liu Z; Nie M; Wu X
Zhonghua Yi Xue Za Zhi; 2015 May; 95(20):1568-71. PubMed ID: 26463603
[TBL] [Abstract][Full Text] [Related]
31. GNRHR-related central hypogonadism with spontaneous recovery - case report.
Šmigoc Schweiger D; Davidović Povše M; Trebušak Podkrajšek K; Battelino T; Avbelj Stefanija M
Ital J Pediatr; 2022 Nov; 48(1):184. PubMed ID: 36371229
[TBL] [Abstract][Full Text] [Related]
32. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
Zacharin M; Sabin MA; Nair VV; Dabadghao P
Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
[TBL] [Abstract][Full Text] [Related]
33. Changes in levels of testosterone, insulin sensitivity and metabolic profiles during GnRH therapy: Reciprocity between insulin sensitivity and pituitary responsiveness to GnRH in teenage and young male patients with congenital hypogonadotropic hypogonadism.
Fan HQ; Wang YC; He W; Zhou HW; Yang T
Clin Endocrinol (Oxf); 2022 Dec; 97(6):783-791. PubMed ID: 36181235
[TBL] [Abstract][Full Text] [Related]
34. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
35. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin.
Warne DW; Decosterd G; Okada H; Yano Y; Koide N; Howles CM
Fertil Steril; 2009 Aug; 92(2):594-604. PubMed ID: 18930225
[TBL] [Abstract][Full Text] [Related]
36. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
[TBL] [Abstract][Full Text] [Related]
37. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.
Bouloux PM; Nieschlag E; Burger HG; Skakkebaek NE; Wu FC; Handelsman DJ; Baker GH; Ochsenkuehn R; Syska A; McLachlan RI; Giwercman A; Conway AJ; Turner L; van Kuijk JH; Voortman G
J Androl; 2003; 24(4):604-11. PubMed ID: 12826700
[TBL] [Abstract][Full Text] [Related]
38. Pulsatile Gonadotropin-Releasing Hormone Therapy Is Associated With Better Spermatogenic Outcomes than Gonadotropin Therapy in Patients With Pituitary Stalk Interruption Syndrome.
Zhang J; Zhu Y; Zhang R; Liu H; Sun B; Zhang W; Wang X; Nie M; Mao J; Wu X
Endocr Pract; 2024 Feb; 30(2):146-154. PubMed ID: 38029930
[TBL] [Abstract][Full Text] [Related]
39. [Stimulation of spermatogenesis in men with hypogonadotropic hypogonadism].
Rabijewski M
Pol Merkur Lekarski; 2018 Sep; 45(267):126-130. PubMed ID: 30240383
[TBL] [Abstract][Full Text] [Related]
40. Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients.
Mao J; Xu H; Wang X; Huang B; Liu Z; Zhen J; Nie M; Min L; Wu X
Hum Reprod; 2015 Sep; 30(9):2031-7. PubMed ID: 26141714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
